• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由WTAP调控的LncRNA LINC00200的m6A修饰通过调节Wnt/β-连环蛋白途径加速胶质瘤的肿瘤发生。

The m6A modification of LncRNA LINC00200 regulated by WTAP accelerates glioma tumorigenesis by regulating Wnt/β-catenin pathway.

作者信息

Lu Zhiying, Chen Jing, Luo Chao

机构信息

Department of Pediatrics, Wuhan Fourth Hospital, No.76, Jiefang Avenue, Qiaokou District, Wuhan, 430034, Hubei, China.

出版信息

Cell Div. 2025 Apr 23;20(1):10. doi: 10.1186/s13008-025-00155-z.

DOI:10.1186/s13008-025-00155-z
PMID:40269865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12020130/
Abstract

BACKGROUND

Several studies have delineated that dysregulated N6-methyladenosine (m6A) regulators participate in glioma progression. The objective of this study is to investigate the mechanism of Wilms' tumor 1-associating protein (WTAP)-mediated m6A modification of long noncoding RNA (lncRNA) LINC00200 in glioma.

METHODS

The LINC00200 expression in glioma was analyzed by qRT-PCR. The expressions of WTAP and Wnt/β-catenin pathway associated proteins were determined via qRT-PCR or western blotting. The levels of WTAP-mediated m6A modification of LINC00200 was ascertained by MeRIP-qPCR. Functionally, the effects of LINC00200 knockdown and the interaction of WTAP with LINC00200 on the glioma cell characteristics were examined by CCK8, colony formation, and transwell migration/invasion assays. In vivo experiments were performed to verify the effect of LINC00200 on tumor growth.

RESULTS

LINC00200 was overexpressed in glioma, and high LINC00200 level was related to higher-grade tumor. Moreover, its knockdown inhibited the malignant properties and expression of molecules related to Wnt/β-catenin pathway in glioma cell lines. In vivo, LINC00200 knockdown attenuated tumor growth. WTAP was also overexpressed in glioma tissues and demonstrated a positive association with LINC00200 expression. Furthermore, the relative enrichment of LINC00200 m6A was enhanced/reduced in a WTAP-dependent manner. Meanwhile, silencing LINC00200 partially reversed the malignant effects of WTAP overexpression in glioma.

CONCLUSION

These results demonstrate that WTAP-mediated m6A modification of LINC00200 promotes glioma progression by modulating Wnt/β-catenin pathway.

摘要

背景

多项研究表明,失调的N6-甲基腺苷(m6A)调节因子参与神经胶质瘤进展。本研究旨在探讨威尔姆斯瘤1相关蛋白(WTAP)介导的长链非编码RNA(lncRNA)LINC00200的m6A修饰在神经胶质瘤中的作用机制。

方法

采用qRT-PCR分析神经胶质瘤中LINC00200的表达。通过qRT-PCR或蛋白质免疫印迹法检测WTAP及Wnt/β-连环蛋白信号通路相关蛋白的表达。采用甲基化RNA免疫沉淀定量PCR(MeRIP-qPCR)确定WTAP介导的LINC00200的m6A修饰水平。功能上,通过CCK8、集落形成及Transwell迁移/侵袭实验检测LINC00200敲低以及WTAP与LINC00200相互作用对神经胶质瘤细胞特性的影响。进行体内实验以验证LINC00200对肿瘤生长的影响。

结果

LINC00200在神经胶质瘤中过表达,且LINC00200高表达与高级别肿瘤相关。此外,敲低LINC00200可抑制神经胶质瘤细胞系的恶性特性及与Wnt/β-连环蛋白信号通路相关分子的表达。在体内,敲低LINC00200可减缓肿瘤生长。WTAP在神经胶质瘤组织中也过表达,且与LINC00200表达呈正相关。此外,LINC00200的m6A相对富集以WTAP依赖的方式增强/降低。同时,沉默LINC00200可部分逆转WTAP过表达对神经胶质瘤的恶性影响。

结论

这些结果表明,WTAP介导的LINC00200的m6A修饰通过调节Wnt/β-连环蛋白信号通路促进神经胶质瘤进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/12020130/98e8633f6074/13008_2025_155_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/12020130/772b3c31c1ab/13008_2025_155_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/12020130/87fd70667f59/13008_2025_155_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/12020130/bed7866df4a5/13008_2025_155_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/12020130/792b6805b36c/13008_2025_155_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/12020130/98e8633f6074/13008_2025_155_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/12020130/772b3c31c1ab/13008_2025_155_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/12020130/87fd70667f59/13008_2025_155_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/12020130/bed7866df4a5/13008_2025_155_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/12020130/792b6805b36c/13008_2025_155_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9b7/12020130/98e8633f6074/13008_2025_155_Fig5_HTML.jpg

相似文献

1
The m6A modification of LncRNA LINC00200 regulated by WTAP accelerates glioma tumorigenesis by regulating Wnt/β-catenin pathway.由WTAP调控的LncRNA LINC00200的m6A修饰通过调节Wnt/β-连环蛋白途径加速胶质瘤的肿瘤发生。
Cell Div. 2025 Apr 23;20(1):10. doi: 10.1186/s13008-025-00155-z.
2
WTAP promotes laryngeal carcinoma cell progression by posttranscriptional activation of CTHRC1 in an m6A-YTHDF1-dependent way.WTAP通过m6A-YTHDF1依赖性方式对CTHRC1进行转录后激活,从而促进喉癌细胞进展。
Cytotechnology. 2024 Dec;76(6):709-720. doi: 10.1007/s10616-024-00648-9. Epub 2024 Aug 1.
3
WTAP-mediated N6-methyladenosine mRNA methylation regulates laser-induced macular neovascularization.WTAP介导的N6-甲基腺苷mRNA甲基化调节激光诱导的黄斑新生血管形成。
Mol Vis. 2024 Oct 8;30:336-347. eCollection 2024.
4
EXOSC2 Mediates the Pro-tumor Role of WTAP in Breast Cancer Cells via Activating the Wnt/β-Catenin Signal.EXOSC2 通过激活 Wnt/β-连环蛋白信号促进 WTAP 在乳腺癌细胞中的促肿瘤作用。
Mol Biotechnol. 2024 Sep;66(9):2569-2582. doi: 10.1007/s12033-023-00834-8. Epub 2023 Oct 19.
5
WTAP-Involved the m6A Modification of lncRNA FAM83H-AS1 Accelerates the Development of Gastric Cancer.WTAP 参与 lncRNA FAM83H-AS1 的 m6A 修饰加速胃癌的发展。
Mol Biotechnol. 2024 Aug;66(8):1883-1893. doi: 10.1007/s12033-023-00810-2. Epub 2023 Jul 21.
6
WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner.WTAP介导的环状EEF2的N6-甲基腺嘌呤修饰通过以IGF2BP2依赖的方式稳定CANT1促进肺腺癌肿瘤发生。
Mol Biotechnol. 2025 Apr;67(4):1494-1508. doi: 10.1007/s12033-024-01134-5. Epub 2024 Apr 15.
7
WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.WTAP通过以m6A依赖的方式调节ALB,促进骨肉瘤的肿瘤发生。
Genomics. 2023 Jan 20:110566. doi: 10.1016/j.ygeno.2023.110566.
8
WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells and I.WTAP 通过调控 PDK4 的 N6-甲基腺苷修饰来调节结直肠癌细胞的恶性行为
Curr Med Chem. 2023;30(29):3368-3381. doi: 10.2174/0929867329666220922102949.
9
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.WTAP 通过 m6A-HuR 依赖的 ETS1 表观遗传沉默促进肝细胞癌进展。
Mol Cancer. 2019 Aug 22;18(1):127. doi: 10.1186/s12943-019-1053-8.
10
WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.WTAP 通过以 m6A 依赖的方式调节 ALB 促进骨肉瘤的肿瘤发生。
Environ Toxicol. 2023 Jun;38(6):1455-1465. doi: 10.1002/tox.23780. Epub 2023 Mar 29.

本文引用的文献

1
Non-Coding RNAs in Human Cancer and Other Diseases: Overview of the Diagnostic Potential.非编码 RNA 在人类癌症和其他疾病中的作用:诊断潜力概述。
Int J Mol Sci. 2023 Nov 11;24(22):16213. doi: 10.3390/ijms242216213.
2
Insights into the regulatory role of RNA methylation modifications in glioma.揭示 RNA 甲基化修饰在神经胶质瘤中的调控作用。
J Transl Med. 2023 Nov 14;21(1):810. doi: 10.1186/s12967-023-04653-y.
3
Crosstalk between Wnt/β-catenin signaling pathway and DNA damage response in cancer: a new direction for overcoming therapy resistance.
癌症中Wnt/β-连环蛋白信号通路与DNA损伤反应之间的相互作用:克服治疗耐药性的新方向。
Front Pharmacol. 2023 Aug 2;14:1230822. doi: 10.3389/fphar.2023.1230822. eCollection 2023.
4
METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/β-catenin signaling.METTL3 介导的 LINC00839 m6A 修饰通过激活 Wnt/β-catenin 信号通路维持胶质瘤干细胞和辐射抗性。
Cell Death Dis. 2023 Jul 12;14(7):417. doi: 10.1038/s41419-023-05933-7.
5
Novel methylation-related long non-coding RNA clinical outcome prediction method: the clinical phenotype and immune infiltration research in low-grade gliomas.新型甲基化相关长链非编码RNA临床结局预测方法:低级别胶质瘤的临床表型与免疫浸润研究
Front Oncol. 2023 May 9;13:1177120. doi: 10.3389/fonc.2023.1177120. eCollection 2023.
6
Pericyte-Glioblastoma Cell Interaction: A Key Target to Prevent Glioblastoma Progression.周细胞-神经胶质瘤细胞相互作用:预防神经胶质瘤进展的关键靶点。
Cells. 2023 May 5;12(9):1324. doi: 10.3390/cells12091324.
7
The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.长链非编码RNA表观遗传学:m6A和m5C长链非编码RNA修饰在癌症中的意义
Front Oncol. 2023 Mar 9;13:1063636. doi: 10.3389/fonc.2023.1063636. eCollection 2023.
8
DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets.低级别胶质瘤中的DNA甲基化与组蛋白修饰:当前认识与潜在临床靶点
Cancers (Basel). 2023 Feb 20;15(4):1342. doi: 10.3390/cancers15041342.
9
Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.WTAP 在癌症中的作用:从机制到治疗潜力。
Biomolecules. 2022 Sep 2;12(9):1224. doi: 10.3390/biom12091224.
10
RNA mA Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications.癌症中的RNA mA修饰:分子机制与潜在临床应用
Innovation (Camb). 2020 Nov 4;1(3):100066. doi: 10.1016/j.xinn.2020.100066. eCollection 2020 Nov 25.